Fords, NJ, United States of America

Jennifer Hickey

This inventor holds 1 USPTO granted patent. Top assignee: Zealand Pharma A/s. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer Hickey. Retrieved from https://idiyas.com/inventor/jennifer-hickey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jennifer Hickey and Pharmaceutical Innovation

Introduction

Jennifer Hickey is an inventor associated with Fords, New Jersey, and pharmaceutical research. The information provided identifies her as a woman and lists one patent connected with Zealand Pharma A/S.

Latest Patents

Hickey is named on one patent, “Compounds Targeting ALPHA4-BETA7 Integrin.” It describes compounds of formula (I), along with their pharmaceutically acceptable salts and solvates. These compounds act as α4β7 antagonists and are described as potentially useful in preventing or treating inflammatory conditions and autoimmune diseases, particularly inflammatory bowel disease. The supplied information lists 1 patent.

Career Highlights

The patent reflects work on compounds intended to target α4β7 integrin, a focus relevant to research into inflammatory and autoimmune diseases. Hickey is associated with Zealand Pharma A/S.

Collaborations

Andrew Roughton is identified as Hickey’s coworker. The supplied information does not specify his role in the patent or the research.

Conclusion

Jennifer Hickey’s listed patent connects her to pharmaceutical innovation focused on α4β7 antagonists and potential treatments for inflammatory bowel disease and related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…